Selecting the Patient Population When Investigating Perioperative Octreotide for Carcinoid Crisis

Pharmacy Times interviewed Rodney Pommier, MD, FACS, professor of surgery, division of surgical oncology, school of medicine, Oregon Health & Science University, on his presentation at the 2021 NANETS Multidisciplinary Neuroendocrine Tumors Medical Virtual Symposium discussing a prospective study of carcinoid crisis with no perioperative octreotide.

During the interview, Pommier discussed the selection of the patient populations included in the prospective study and how those patients were selected.